NCT03181867 2026-01-21
18F-DCFPyL PET/CT in High Risk and Recurrent Prostate Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Enrolling by invitation
Clinical Trials
4 trialsNCT07023848 2025-06-17
PET Image Exploration of 89Zr-labeled Antibody Fragments Targeting HER2 in Patients With Malignant Tumors
Affiliated Hospital of Jiangnan University
Phase EARLY_PHASE1 Enrolling by invitation
NCT07023861 2025-06-17
The Exploration of Novel Radionuclide-labeled HER2-targeting Antibodies in the Diagnosis of HER2-positive Malignancies
Affiliated Hospital of Jiangnan University
Phase EARLY_PHASE1 Enrolling by invitation
NCT06723665 2025-01-24
The Exploration of 18F-PSMA-1007 PET/CT Imaging in Prostate Cancer Patients
Affiliated Hospital of Jiangnan University
Phase NA Enrolling by invitation